scholarly article | Q13442814 |
P356 | DOI | 10.1042/CBI20100524 |
P698 | PubMed publication ID | 22050182 |
P50 | author | Yangsoo Jang | Q59695831 |
P2093 | author name string | Ki-Chul Hwang | |
Min-Ji Cha | |||
Jung-Sun Kim | |||
Il-Kwon Kim | |||
Eunmi Choi | |||
Onju Ham | |||
Byeong-Wook Song | |||
Soyeon Lim | |||
Heesang Song | |||
Se-Yeon Lee | |||
P2860 | cites work | The mechanisms of action of PPARs | Q28216953 |
PPAR-gamma inhibits ANG II-induced cell growth via SHIP2 and 4E-BP1 | Q28578260 | ||
ANG II type 2 receptor regulates smooth muscle growth and force generation in late fetal mouse development | Q30434317 | ||
Angiotensin-induced EGF receptor transactivation inhibits insulin signaling in C9 hepatic cells. | Q34180196 | ||
The renin-angiotensin system and vascular hypertrophy | Q34400269 | ||
Thiazolidinedione regulation of smooth muscle cell proliferation | Q35609211 | ||
Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system | Q36548154 | ||
Involvement of connexin 43 in angiotensin II-induced migration and proliferation of saphenous vein smooth muscle cells via the MAPK-AP-1 signaling pathway | Q37395007 | ||
Akt is a major downstream target of PI3-kinase involved in angiotensin II-induced proliferation | Q40665812 | ||
Troglitazone inhibits angiotensin II-induced extracellular signal-regulated kinase 1/2 nuclear translocation and activation in vascular smooth muscle cells | Q41676053 | ||
The inhibition of insulin-stimulated proliferation of vascular smooth muscle cells by rosiglitazone is mediated by the Akt-mTOR-P70S6K pathway | Q43211170 | ||
Fluvastatin enhances the inhibitory effects of a selective angiotensin II type 1 receptor blocker, valsartan, on vascular neointimal formation | Q44271062 | ||
Phosphatidylinositol 3-kinase in angiotensin II-induced hypertrophy of vascular smooth muscle cells | Q44614710 | ||
PPAR(gamma) agonist rosiglitazone improves vascular function and lowers blood pressure in hypertensive transgenic mice | Q44743365 | ||
ANG II activates effectors of mTOR via PI3-K signaling in human coronary smooth muscle cells | Q45022808 | ||
Preventative effects of rosiglitazone on restenosis after coronary stent implantation in patients with type 2 diabetes. | Q45124478 | ||
PPARgamma agonist, rosiglitazone, regulates angiotensin II-induced vascular inflammation through the TLR4-dependent signaling pathway. | Q46006542 | ||
Caveolin-1 is essential for activation of Rac1 and NAD(P)H oxidase after angiotensin II type 1 receptor stimulation in vascular smooth muscle cells: role in redox signaling and vascular hypertrophy | Q46564947 | ||
Combined angiotensin II type 1 and type 2 receptor blockade on vascular remodeling and matrix metalloproteinases in resistance arteries | Q46618559 | ||
Angiotensin IV enhances phosphorylation of 4EBP1 by multiple signaling events in lung endothelial cells | Q46846204 | ||
Peroxisome proliferator-activated receptor gamma regulates angiotensin II-stimulated phosphatidylinositol 3-kinase and mitogen-activated protein kinase in blood vessels in vivo | Q46847915 | ||
Antiproliferative mechanisms of raxofelast (IRFI-016) in H2O2-stimulated rat aortic smooth muscle cells | Q47241376 | ||
Rosiglitazone inhibits angiotensin II-induced CTGF expression in vascular smooth muscle cells - role of PPAR-gamma in vascular fibrosis. | Q53590760 | ||
P433 | issue | 3 | |
P921 | main subject | (RS)-rosiglitazone | Q424771 |
P304 | page(s) | 305-310 | |
P577 | publication date | 2012-03-01 | |
P1433 | published in | Cell Biology International | Q1254690 |
P1476 | title | Anti-proliferative effect of rosiglitazone on angiotensin II-induced vascular smooth muscle cell proliferation is mediated by the mTOR pathway | |
P478 | volume | 36 |
Q36926148 | Common drugs and treatments for cancer and age-related diseases: revitalizing answers to NCI's provocative questions |
Q50033960 | Gliclazide, a KATP channel blocker, inhibits vascular smooth muscle cell proliferation through the CaMKKβ-AMPK pathway |
Q53281676 | MicroRNA-365 inhibits the proliferation of vascular smooth muscle cells by targeting cyclin D1. |
Q40458029 | MicroRNA-761 inhibits Angiotensin II-induced vascular smooth muscle cell proliferation and migration by targeting mammalian target of rapamycin. |
Q35884929 | Pioglitazone attenuates vascular fibrosis in spontaneously hypertensive rats |
Q37510124 | Podocyte-specific GLUT4-deficient mice have fewer and larger podocytes and are protected from diabetic nephropathy. |
Q53003922 | Regulation of mitochondrial morphology by positive feedback interaction between PKCδ and Drp1 in vascular smooth muscle cell. |
Q44629243 | Role of Akt signaling pathway in delayed cerebral vasospasm after subarachnoid hemorrhage in rats |
Q27309387 | Rosiglitzone suppresses angiotensin II-induced production of KLF5 and cell proliferation in rat vascular smooth muscle cells |
Search more.